Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study.
Nicola ConranClaudia de Alvarenga MaximoThais OliveiraKleber Yotsumoto FertrinClarisse LoboFernando F CostaPublished in: British journal of haematology (2022)
Keyphrases